Adaptive Biotechnologies ADPT 深 滬
等待開盤 08-20 09:30:00 美东时间
12.57
+0.160
+1.29%
華盛通- 最 高12.71
- 今 開12.36
- 成交量 112.76万股
- 最 低 12.2523
- 昨 收 12.41
- 總市值 19.11亿
- 52周最高 13.37
- 市盈率 靜 --
- 換手率 0.74%
- 52周最低 3.981
- 委 比 22.31%
- 總股本 1.52亿
- 歷史最高 71.25
- 量 比 0.66
- 振 幅 3.69%
- 歷史最低 2.28
- 每 手 1
- 風險率 2.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What to Expect from Sotera Health's Earnings
Sotera Health (NASDAQ:SHC) will release its quarterly earnings report on Friday...
08-07 22:04
美股大行评级 | Rivian遭多家大行下调目标价；巴克莱上调超微公司目标价从130美元升至200美元
今日重点评级关注：韦德布什：维持Gossamer Bio"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持EyePoint Pharmaceuticals"买入"评级，目标价从22美元升至23美元
08-07 09:46
Piper Sandler Maintains Overweight on Adaptive Biotechnologies, Raises Price Target to $15
Piper Sandler analyst David Westenberg maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the price target from $13 to $15.
08-06 23:54
Analysts’ Top Healthcare Picks: Cogent Biosciences (COGT), Adaptive Biotechnologies (ADPT)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
08-06 18:50
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers BiomX (AMEX:PHGE) shares moved upwards by 40.1% to $0.61 during Tuesda...
08-06 05:07
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Vivakor Confirms Special Dividend of Adapti, Inc. Record Date Set for August 20, 2025
Vivakor, Inc. announced a record date of August 20, 2025, for a special dividend to shareholders. The dividend will be in the form of Adapti, Inc. common stock, with each Vivakor shareholder receiving approximately 0.0079 shares of Adapti based on the current stock price of $3.50, valuing the dividend at approximately $0.75 million. Vivakor currently holds 13.5% of Adapti's outstanding shares. Adapti recently completed its SEC registration and fi...
07-31 12:30
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics
Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.
07-26 13:25
Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
Adaptive Biotechnologies announced it will report Q2 2025 financial results after market close on August 5, 2025, with a webcast conference call starting at 1:30 p.m. PT / 4:30 p.m. ET. The company specializes in translating adaptive immune system genetics into clinical products for disease diagnosis and treatment, focusing on Minimal Residual Disease and Immune Medicine. Live audio and a replay archive will be available on its website. Contact d...
07-15 20:05
Adaptive Biotechnologies Integrates Adaptive's clonosSEQ Test For MRD Assessment In Lymphoid Malignancies Into OncoEMR, Flatiron's Cloud-Based EMR Platform
Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, and
07-01 19:31
